Works matching IS 14397595 AND DT 2022 AND VI 32 AND IP 4

Results: 23

Use of mycophenolate mofetil for systemic sclerosis and systemic sclerosis-associated interstitial lung disease: Information from a Japanese hospital claims database.

Published in:

Modern Rheumatology, 2022, v. 32, n. 4, p. 755, doi. 10.1093/mr/roab111

By:

Takashi Funatogawa;
Yusuke Narita;
Aya Tamura;
Kazuma Mii;
Yasuo Sugitani;
Tomoaki Uchida

Publication type:

Article

SAPHO syndrome and pustulotic arthro-osteitis.

Published in:

Modern Rheumatology, 2022, v. 32, n. 4, p. 665, doi. 10.1093/mr/roab103

By:

Mitsumasa Kishimoto;
Yoshinori Taniguchi;
Shigeyoshi Tsuji;
Yoko Ishihara;
Deshpande, Gautam A.;
Keizo Maeda;
Masato Okada;
Yoshinori Komagata;
Satomi Kobayashi;
Yukari Okubo;
Tetsuya Tomita;
Shinya Kaname

Publication type:

Article

Long-term safety and effectiveness of mycophenolate mofetil in adults with lupus nephritis: a real-world study in Japan.

Published in:

Modern Rheumatology, 2022, v. 32, n. 4, p. 746, doi. 10.1093/mr/roab076

By:

Tsutomu Takeuchi;
Hideyuki Hashimoto;
Mika Matsumoto

Publication type:

Article

A pooled analysis of serious infections and herpes zoster-related disease in Asian patients with rheumatoid arthritis treated with peficitinib (ASP015K) over a median of 3 years.

Published in:

Modern Rheumatology, 2022, v. 32, n. 4, p. 708, doi. 10.1093/mr/roab069

By:

Yoshiya Tanaka;
Tsutomu Takeuchi;
Daisuke Kato;
Yuichiro Kaneko;
Musashi Fukuda;
Hiroyuki Izutsu;
Mitsuhiro Rokuda

Publication type:

Article

Real-world safety and efficacy of CT-P13, an infliximab biosimilar, in Japanese rheumatoid arthritis patients naïve to or switched from biologics.

Published in:

Modern Rheumatology, 2022, v. 32, n. 4, p. 718, doi. 10.1093/mr/roab068

By:

Tsutomu Takeuchi;
Kiyohiro Nishikawa;
Fumika Yamada;
Shiro Ohshima;
Makoto Inoue;
Yutaka Yoshioka;
Hisashi Yamanaka

Publication type:

Article

Differences in patients' population and efficacy/effectiveness of biologic disease-modifying antirheumatic drugs between randomized controlled trials and real-world settings in patients with rheumatoid arthritis - using the IORRA cohort.

Published in:

Modern Rheumatology, 2022, v. 32, n. 4, p. 675, doi. 10.1093/mr/roab067

By:

Eri Sugano;
Eiichi Tanaka;
Eisuke Inoue;
Ryoko Sakai;
Mai Abe;
Kumiko Saka;
Naohiro Sugitani;
Moeko Ochiai;
Rei Yamaguchi;
Yoko Higuchi;
Naoki Sugimoto;
Katsunori Ikari;
Ayako Nakajima;
Hisashi Yamanaka;
Masayoshi Harigai

Publication type:

Article

Immunogenicity of sarilumab and impact on safety and efficacy in Japanese patients with rheumatoid arthritis: analysis of two Phase 3 randomised clinical trials.

Published in:

Modern Rheumatology, 2022, v. 32, n. 4, p. 686, doi. 10.1093/mr/roab066

By:

Yoshiya Tanaka;
Toshiya Takahashi;
Mariko Sumi;
Owen Hagino;
Van Hoogstraten, Hubert;
Xu, Christine;
Naoto Kato;
Hideto Kameda

Publication type:

Article

What is the impact of methotrexate on liver in patients with juvenile idiopathic arthritis? Results of liver SWE performed in a single centre.

Published in:

Modern Rheumatology, 2022, v. 32, n. 4, p. 776, doi. 10.1093/mr/roab064

By:

Güngörer, Vildan;
Öztürk, Mehmet;
Özlü, Mustafa Yasir;
Arslan, Sükrü

Publication type:

Article

Role of dietary patterns and factors in determining the risk of knee osteoarthritis: A meta-analysis.

Published in:

Modern Rheumatology, 2022, v. 32, n. 4, p. 815, doi. 10.1093/mr/roab059

By:

Chao Xu;
Shun Wang;
Weiye Ti;
Jun Yang;
Yalikun Yasen;
Miryaqup Memetsidiq;
Song-qing Shi

Publication type:

Article

Impact of age on the efficacy and safety of peficitinib (ASP015K) for the treatment of rheumatoid arthritis.

Published in:

Modern Rheumatology, 2022, v. 32, n. 4, p. 696, doi. 10.1093/mr/roab058

By:

Yoshiya Tanaka;
Tsutomu Takeuchi;
Daisuke Kato;
Yuichiro Kaneko;
Musashi Fukuda;
Daisuke Miyatake

Publication type:

Article

Tacrolimus as an alternative treatment for patients with juvenile idiopathic arthritis.

Published in:

Modern Rheumatology, 2022, v. 32, n. 4, p. 783, doi. 10.1093/mr/roab055

By:

Susumu Yamazaki;
Masaki Shimizu;
Yuko Akutsu;
Asami Shimbo;
Masaaki Mori

Publication type:

Article

Predictors of persistent inflammation in children with familial Mediterranean fever.

Published in:

Modern Rheumatology, 2022, v. 32, n. 4, p. 803, doi. 10.1093/mr/roab054

By:

Yildirim, Deniz Gezgin;
Senol, Pelin Esmeray;
Söylemezoğlu, Oğuz

Publication type:

Article

Evaluation of vitamin D profile in juvenile idiopathic arthritis.

Published in:

Modern Rheumatology, 2022, v. 32, n. 4, p. 792, doi. 10.1093/mr/roab053

By:

Madhumita Nandi;
Md Abu Sayeed Mullick;
Arnab Nandy;
Moumita Samanta;
Sumantra Sarkar;
Tapas Kumar Sabui

Publication type:

Article

Urticaria and increased risk of rheumatoid arthritis: a two-sample Mendelian randomisation study in European population.

Published in:

Modern Rheumatology, 2022, v. 32, n. 4, p. 736, doi. 10.1093/mr/roab052

By:

Xue Yu;
Ming-Gang Deng;
Zi-Ying Tang;
Zhi-Jiang Zhang

Publication type:

Article

Mast cells can produce transforming growth factor β1 and promote tissue fibrosis during the development of Sjögren's syndrome-related sialadenitis.

Published in:

Modern Rheumatology, 2022, v. 32, n. 4, p. 761, doi. 10.1093/mr/roab051

By:

Shinjiro Kaieda;
Kyoko Fujimoto;
Keita Todoroki;
Yushi Abe;
Jingo Kusukawa;
Tomoaki Hoshino;
Hiroaki Ida

Publication type:

Article

Ultrasound assessment of sarcopenia in patients with rheumatoid arthritis.

Published in:

Modern Rheumatology, 2022, v. 32, n. 4, p. 728, doi. 10.1093/mr/roab049

By:

Takeshi Yoshida;
Yoshitaka Kumon;
Naoko Takamatsu;
Taiki Nozaki;
Masataka Inoue;
Hiroyuki Nodera;
Jemima Albayda;
Yuishin Izumi

Publication type:

Article

Efficacy and safety of canakinumab for colchicine-resistant or colchicine-intolerant familial Mediterranean fever: A single-centre observational study.

Published in:

Modern Rheumatology, 2022, v. 32, n. 4, p. 797, doi. 10.1093/mr/roab048

By:

Takuya Tomokawa;
Tomohiro Kogaa;
Yushiro Endo;
Toru Michitsuji;
Atsushi Kawakami

Publication type:

Article

Epidemiological study of osteonecrosis of the femoral head using the national registry of designated intractable diseases in Japan.

Published in:

Modern Rheumatology, 2022, v. 32, n. 4, p. 808, doi. 10.1093/mr/roab047

By:

Ryuichi Sato;
Wataru Ando;
Wakaba Fukushima;
Takashi Sakai;
Hidetoshi Hamada;
Masaki Takao;
Kazuya Ito;
Nobuhiko Sugano

Publication type:

Article

Deformity analysis of the lower limb on the coronal plane in patients with rheumatoid arthritis and osteoarthritis.

Published in:

Modern Rheumatology, 2022, v. 32, n. 4, p. 741, doi. 10.1093/mr/roab046

By:

Shuntaro Nejima;
Hiroshi Fujimaki;
Ken Kumagai;
Hyonmin Choe;
Hiroyuki Ike;
Taro Tezuka;
Kensuke Hisatomi;
Akiko Nagaoka;
Yutaka Inaba

Publication type:

Article

Evaluation of locomotive syndrome in patients receiving surgical treatment for degenerative musculoskeletal diseases: A multicentre prospective study using the new criteria.

Published in:

Modern Rheumatology, 2022, v. 32, n. 4, p. 822, doi. 10.1093/mr/roab045

By:

Satoshi Kato;
Satoru Demura;
Tamon Kabata;
Hidenori Matsubara;
Yuki Kurokawa;
Yoshitomo Kajino;
Yoshiyuki Okamoto;
Kazunari Kuroda;
Hiroaki Kimura;
Kazuya Shinmura;
Noriaki Yokogawa;
Takaki Shimizu;
Kentaro Igarashi;
Daisuke Inoue;
Hiroyuki Tsuchiya

Publication type:

Article

Procollagen I N-terminal peptide correlates with inflammation on sacroiliac joint magnetic resonance imaging in ankylosing spondylitis but not in non-radiographic axial spondyloarthritis: A cross-sectional study.

Published in:

Modern Rheumatology, 2022, v. 32, n. 4, p. 770, doi. 10.1093/mr/roab044

By:

Xuegang Li;
Anqi Liang;
Yufeng Chen;
Lam, Nelson SiuKei;
Xinxin Long;
Xianghe Xu;
Shuping Zhong

Publication type:

Article

The real-world effectiveness of anti-RANKL antibody denosumab on the clinical fracture prevention in patients with rheumatoid arthritis: The ANSWER cohort study.

Published in:

Modern Rheumatology, 2022, v. 32, n. 4, p. 834, doi. 10.1093/mr/roab043

By:

Koichi Murata;
Ryuji Uozumi;
Motomu Hashimoto;
Kosuke Ebina;
Kengo Akashi;
Akira Onishi;
Koji Nagai;
Ayaka Yoshikawa;
Masaki Katayama;
Yonsu Son;
Hideki Amuro;
Ryota Hara;
Wataru Yamamoto;
Ryu Watanabe;
Kosaku Murakami;
Masao Tanaka;
Hiromu Ito;
Akio Morinobu;
Shuichi Matsuda

Publication type:

Article

Dipeptidyl peptidase-4 inhibitor use is associated with a lower erythrocyte sedimentation rate in patients with remitting seronegative symmetrical synovitis with pitting oedema and pre-existing diabetes mellitus.

Published in:

Modern Rheumatology, 2022, v. 32, n. 4, p. 830, doi. 10.1093/mr/roab036

By:

Yoshiro Horai;
Toshimasa Shimizu;
Akitomo Okadae;
Junichi Tokumitsu;
Toshiyuki Ikeoka;
Genpei Kuriya;
Nozomi Iwanaga;
Yasumori Izumi;
Tomoki Origuchi;
Atsushi Kawakami

Publication type:

Article